Key result
In 2001, heart failure in Belgium accounted for 19,398 admissions, a mean hospital stay of 14.8 days, and total in-hospital costs of €94,113,827, representing 1.8% of total hospital expenditure.
Why the study?
What is the impact of heart failure on hospital activity and healthcare costs in Belgium?
Observational (n=19,398)
Yes
What is the impact of heart failure on hospital activity and healthcare costs in Belgium?
Heart failure causes a significant burden on hospital activity and healthcare costs in Belgium, accounting for 1.8% of total hospital expenditure in 2001.
Documents substantial 2001 Belgian HF hospitalization costs; leaves open whether modern therapies have altered this burden.
Heart failure (HF) is a serious public health problem worldwide. It has a high prevalence, affects mainly the elderly and causes high mortality or disability with high economic costs. The aim of the present study was to calculate the number of admissions for HF, the total in-hospital stay, the mean length of in-hospital stay and the in-hospital costs due to HF in Belgium. Retrospective analysis of data from the national hospital registration system provided the following results. In 2001, there were 19,398 admissions with HF as a primary diagnosis, with a total in-hospital stay of 286,938 days. The mean in-hospital stay for HF was 14.8 days. The total in-hospital cost of HF as a primary diagnosis was euro 94,113,827, representing 1.8% of the total hospital expenditure. The limitations of this study are its mere focus on admissions and their characteristics in 2001, and the use of a retrospective analysis. Nevertheless, it led to the conclusion that HF was responsible for a significant number of in-hospital days, with a significant impact on healthcare costs in Belgium.
No takes yet. Share an insight, caveat, or question.
Claes et al. (2008) conducted an observational in Heart failure (n=19,398). In 2001, heart failure in Belgium accounted for 19,398 admissions, a mean hospital stay of 14.8 days, and total in-hospital costs of €94,113,827, representing 1.8% of total hospital expenditure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: